Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Strom

Showing results (171-180 of 658) with videos related to

Pageof 66
Sort By:
Surgery|February 1, 1976
Studies on infiltrating host cells harvested from acutely rejecting rat cardiac allograftsN L Tilney, T B Strom, S G Macpherson, et al.
Transplantation|January 1, 1990
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporineG Walz, B Zanker, L B Melton, et al.
Immunological Reviews|October 1, 1992
Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting moleculesT B Strom, V R Kelley, T G Woodworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1992
An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferationC Díaz-Gallo, M Moscovitch-Lopatin, T B Strom, et al.
Science (New York, N.Y.)|July 13, 1973
Microtubule function in immune and nonimmune lymphocyte-mediated cytotoxicityT B Strom, M R Garovoy, D B Carpenter, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in ratsJ W Kupiec-Weglinski, T Diamantstein, N L Tilney, et al.
Experimental and Clinical Endocrinology|May 1, 1989
Current stage of interleukin 2 receptor targeted therapyT Diamantstein, J W Kupiec-Weglinski, T B Strom, et al.
Transplantation Proceedings|February 1, 1989
Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in miceL V Barrett, J R Murphy, T B Strom, et al.
Transplantation Proceedings|December 26, 2001
Death of alloreactive T cells sets the stage for immunoregulation to actX C Li, A D Wells, L A Turka, et al.
The Journal of Experimental Medicine|February 1, 1976
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancementJ P Soulillou, C B Carpenter, A J d'Apice, et al.
Pageof 66

Showing results (171-180 of 658) with videos related to

Sort By:
Pageof 66
Surgery|February 1, 1976
Studies on infiltrating host cells harvested from acutely rejecting rat cardiac allograftsN L Tilney, T B Strom, S G Macpherson, et al.
Transplantation|January 1, 1990
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporineG Walz, B Zanker, L B Melton, et al.
Immunological Reviews|October 1, 1992
Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting moleculesT B Strom, V R Kelley, T G Woodworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1992
An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferationC Díaz-Gallo, M Moscovitch-Lopatin, T B Strom, et al.
Science (New York, N.Y.)|July 13, 1973
Microtubule function in immune and nonimmune lymphocyte-mediated cytotoxicityT B Strom, M R Garovoy, D B Carpenter, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in ratsJ W Kupiec-Weglinski, T Diamantstein, N L Tilney, et al.
Experimental and Clinical Endocrinology|May 1, 1989
Current stage of interleukin 2 receptor targeted therapyT Diamantstein, J W Kupiec-Weglinski, T B Strom, et al.
Transplantation Proceedings|February 1, 1989
Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in miceL V Barrett, J R Murphy, T B Strom, et al.
Transplantation Proceedings|December 26, 2001
Death of alloreactive T cells sets the stage for immunoregulation to actX C Li, A D Wells, L A Turka, et al.
The Journal of Experimental Medicine|February 1, 1976
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancementJ P Soulillou, C B Carpenter, A J d'Apice, et al.
Pageof 66